Seizure Prophylaxis After Brain Hemorrhage — When to Use, When to Avoid, and Which Agent to Choose
Hossam Qassem, ICU Clinical pharmacist at Mabaret AlAsafra Group for Medical Services, shared a post on LinkedIn:
“Day 74
Seizure Prophylaxis After Brain Hemorrhage — When to Use, When to Avoid, and Which Agent to Choose
Key Clinical Pearls
1. Spontaneous Brain Hemorrhage — overall stance
Routine AED prophylaxis is not recommended for all spontaneous intracranial hemorrhages.
✔ Use selectively based on:
Cortical involvement
Presence of early seizure
Large clot burden
Need for neurosurgical intervention
Evidence of significant cortical irritation on imaging
Why? No evidence AEDs prevent late seizures; unnecessary use increases neurocognitive adverse effects.
2. Intracerebral Hemorrhage (ICH) — selective prophylaxis only
Do NOT use routinely in spontaneous ICH.
✔ Consider prophylaxis when:
Lobar hematoma
Cortical involvement
Hematoma >30 mL
Intraventricular extension
Early seizure at presentation
Post-operative after hematoma evacuation
Agent of choice: Levetiracetam.
3. Subarachnoid Hemorrhage (SAH)
✔ Aneurysmal SAH = Prophylaxis recommended for 3–7 days, especially when:
High Hunt & Hess grade
Cortical irritation
IVH or hydrocephalus
EVD in place
Avoid long-term use unless seizures occur.
Preferred agent: Levetiracetam (better cognitive profile vs phenytoin).
—
4. Traumatic Brain Injury (TBI)
✔ Moderate–severe TBI = 7-day AED prophylaxis
Indications:
GCS ≤ 8
Cortical contusions
Depressed/penetrating skull fractures
Subdural/epidural hematoma
Goal: Prevent early PTS (first 7 days).
AEDs do not prevent late post-traumatic epilepsy.
5. Post-craniotomy / neurosurgical interventions
✔ Prophylaxis recommended in:
Brain tumor resections (especially supratentorial)
Cortical manipulation
Hematoma evacuation
Lobectomy
Usual duration: 7 days, longer if high epileptic potential persists.
6. Agent selection, dosing and ICU pearls
Levetiracetam (Keppra) = preferred
500–1,000 mg IV/PO q12h (adjust for renal function)
No CYP interactions
Better neurocognitive profile
Avoid routine phenytoin unless clinically required (drug interactions, toxicity, monitoring burden).
STOP at 7 days if no seizures and no ongoing risk.
7. When to avoid prophylaxis
Low-risk deep ICH (basal ganglia, thalamus)
Uncomplicated cerebellar hemorrhage
SAH with no cortical involvement and no EVD
Mild TBI without cortical injury
Avoid unnecessary therapy to reduce sedation, encephalopathy, and drug interactions.
Guideline Anchors
Neurocritical Care Society (NCS) Seizure Prophylaxis Guidelines
AHA/ASA ICH and SAH Guidelines
Brain Trauma Foundation TBI Guidelines”
Stay informed with Hemostasis Today.
-
Oct 14, 2026, 07:09Dianne E. van der Wal: A New Chapter in Academia Celebrating a Journey in Research, Teaching and Platelet Science
-
Oct 14, 2026, 06:55Mahdieh Dagina Pedersen: A Meaningful Milestone in Hemophilia A Research and Oral Drug Development
-
Oct 14, 2026, 06:37Neoklis Mparis: Unilateral Adrenal Haemorrhage in Primary Antiphospholipid Syndrome During Bridging Anticoagulation
-
Oct 14, 2026, 06:00Aymen A.: LAAC vs. OAC in Patients with Atrial Fibrillation Including CHAMPION-AF and CLOSURE-AF Trials
-
Oct 13, 2026, 21:05Francisco Chacón-Lozsán: Heparin-Induced Thrombocytopenia – When an Anticoagulant Triggers Thrombosis
-
Oct 13, 2026, 21:04Aref Zribi: Isolated Tumor Thrombus and the Role of Prophylactic Anticoagulation
-
Oct 13, 2026, 21:01Alex Larson: Why Normal Bloodwork Does Not Always Tell the Whole Story
-
Oct 13, 2026, 20:58Juan Jauregui-Lozano: How Replication Stress Impairs Red Blood Cell Maturation
-
Oct 13, 2026, 20:55Caitlin Raymond: Understanding Platelet Refractoriness Before Ordering More Platelets